Patent ID: 8829193

Claim:
A method for treating multiple myeloma comprising administering to a patient in need of such treatment an effective amount of a compound of Formula II: or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, wherein: R 1 is selected from —NH—CO-alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; X represents CH or N; R 2a is selected from —H, —OH, alkyl, alkoxy, haloalkyl, aminoalkyl, hydroxyalkyl, halo, amino and benzoate; R 2b is selected from —H and alkyl; R 3 is selected from H, OH, alkyl, alkoxy and halo; R 4a is selected from —OH, alkyl, alkoxy, haloalkyl, aminoalkyl, hydroxyalkyl, halo and amino; and R 4b is selected from H, alkyl and halo.